Subscribe
Follow Us
Subscribe
Follow Us

Driving Cannabinoid Innovation

Andira Pharmaceuticals is a global leader in cannabinoid therapeutics and medical devices, delivering first-in-class solutions for post-surgical recovery, chronic wounds and early-stage breast cancer.

OUR PIPELINE
Mask Group 39@2x

Unlocking Cannabinoid Synergy to Amplify Therapy

Our unique R&D approach harnesses the synergistic properties of cannabinoids to improve therapeutic efficacy

OUR SCIENCE

Product Pipeline

Andira Pharmaceuticals is the proud developer of first-in-class, locally-administered cannabinoid therapeutics for post-surgical pain and early stage breast cancer. Andira is also the proud developer of SilvanexTM, a breakthrough dual anti-infective + tissue repair technology for therapeutic and medical device application.
PRODUCT PIPELINE

Therapeutics

AND-254 for Post-Mastectomy Pain (PMP)

SilvanexTM Topical for Diabetic Ulcers

AND-259 for Ductal Carcinoma In Situ (DCIS) Breast Cancer

DISCOVERY
PRE-CLINICAL
PHASE I
PHASE II
PHASE III

Therapeutics

DISCOVERY
PRE-CLINICAL
PHASE I
PHASE II
PHASE III

AND-254 for Post-Mastectomy Pain (PMP)

Silvanex™ Topical for Diabetic Ulcers

AND-259 for Ductal Carcinoma In Situ (DCIS) Breast Cancer

Medical Devices

Silvanex™ Surgical for Post-Surgical Wound Care

Silvanex™ IV Site for IV Insertion Sites

DISCOVERY
MANUFACTURABILITY
EFFICACY
BIOCOMPATIBILITY
CLINICAL SAFETY

Medical Devices

DISCOVERY
MANUFACTURABILITY
EFFICACY
BIOCOMPATIBILITY
CLINICAL SAFETY

Silvanex™ Surgical for Post-Surgical Wound Care

Silvanex™ IV Site for IV Insertion Sites

About Us

We are a cannabinoid-focused biopharmaceutical company committed to improving lives & transforming the future of healthcare by advancing world-leading innovation.
OUR COMPANY
Group 18479@2x

LATEST NEWS FROM ANDIRA

Join us in transforming the future of healthcare with our groundbreaking cannabinoid therapeutics and medical devices.

CONTACT US